Literature DB >> 7685683

Efficacy and upper GI safety of diclofenac/misoprostol, piroxicam and naproxen in patients with osteoarthritis.

G S Geis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685683     DOI： 10.2165/00003495-199300451-00005

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis.

Authors:  W Bolten; J A Gomes; H Stead; G S Geis
Journal:  Br J Rheumatol       Date:  1992-11

2.  A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis.

Authors:  W Verdickt; C Moran; H Hantzschel; A M Fraga; H Stead; G S Geis
Journal:  Scand J Rheumatol       Date:  1992       Impact factor: 3.641

3.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

4.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059
  4 in total
  2 in total

Review 1.  Review of the safety of diclofenac/misoprostol.

Authors:  P Gagnier
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 2.  Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.

Authors:  Roy Altman; Bill Bosch; Kay Brune; Paola Patrignani; Clarence Young
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.